-
E-mail
info-china@gerresheimer.com
-
Phone
18661195281
-
Address
Building 3, Rail Transit Industrial Park, No. 355 Longjin Road, Changzhou City, Jiangsu Province
Gresham Plastic Packaging (Changzhou) Co., Ltd
Gresham deepens cooperation with Portal Instruments to jointly promote PRIME Nexus ™ Commercialization of reusable automatic injectors
Date: 2025-10-16Read: 5
•This collaboration aims to support PRIME Nexus based on syringes ™ Development and large-scale manufacturing of reusable and intelligently connected automatic injector platform
•With comprehensive professional capabilities, we are committed to providing end-to-end integrated solutions for pharmaceutical companies developing drugs for the treatment of chronic diseases
Gresheim is a global partner in the pharmaceutical, biotechnology, and skincare industries, committed to providing customers with globally leading innovative systems and solutions. The company recently announced that it will further deepen its cooperation with Portal Instruments, a private medical equipment company, to jointly promote Prime NEXUS ™ Commercial production of reusable and intelligent interconnected automatic injector platform. This collaboration integrates Portal Instruments in Prime NEXUS ™ The innovative technology of the product, as well as Gracheim's global business layout, rich professional knowledge, and capabilities in large-scale equipment manufacturing, provide pharmaceutical companies with integrated end-to-end solutions covering the entire drug delivery process.
This cooperation fully utilizes the respective strengths of both parties and is committed to innovation and sustainable development, "said Daniel Diezi, Senior Vice President of Global Advanced Technology at Gerresheimer." This highlights our position as a supplier of systems and solutions for the pharmaceutical industry, and also demonstrates our firm determination to help customers provide treatment solutions that improve the quality of life for chronic disease patients
We are delighted to deepen our collaboration with Gerresheimer, "said Dr. Patrick Anquetil, CEO of Portal Instruments." This partnership deeply integrates Gerresheimer's capabilities in primary packaging and equipment manufacturing with our strengths in innovative engineering and patient-centered design, providing pharmaceutical companies with a one-stop solution. Customers will accelerate product time to market and effectively reduce the complexity of collaborating with multiple suppliers
Multi purpose automatic injector platform suitable for various drug formulations
PRIME Nexus ™ It is a reusable electromechanical automatic syringe platform developed by Portal Instruments, which is designed to help patients easily achieve convenient and regular subcutaneous self injection, and is used to treat a variety of chronic diseases from diabetes to autoimmune diseases. This automatic injector can be adapted to two specifications of syringes provided by Grachheimer, 1 mL and 2.25 mL, supporting different drug capacities to ensure precise dosage and stable injection. PRIME Nexus ™ Capable of handling drugs of different viscosities (tested up to 600 centipoise), meeting the needs of small and large molecule drug formulations.
Sustainable and interconnected design concepts meet constantly changing needs
With its rechargeable and reusable concept, PRIME Nexus ™ Responding to the industry's growing demand for reducing medical equipment waste and promoting sustainable solutions. Due to all electronic components being integrated into reusable units, the cost of each injection can also be reduced. This reusable two-part design not only enriches Gresham's drug delivery device product portfolio, but also aligns with the company's ecological design philosophy, which is a key component of its sustainable development strategy.
This automatic injector adopts a patient-centered design, making it easy for patients to self administer medication. Its built-in optional connectivity function can help medical personnel monitor patient medication compliance and provide data-driven insights. These design features help enhance the patient experience and optimize treatment outcomes.
Feasibility testing can be conducted immediately
PRIME Nexus ™ Functional and usability testing has been completed, and feasibility testing can now be conducted for specific drug formulations.